McKesson share price logo

McKesson

NYSE: MCK

Large Cap

$971.27

+9.39

(+0.98%)

Live

as on

McKesson Stock Performance

as on October 15, 2026 at 4:12 am IST

  • Day's Low

    Day's High

    $968.50
    $978.05
    downward going graph

    0.29%

    Downside

    0.70%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $723.68
    $999.00
    downward going graph

    25.49%

    Downside

    2.86%

    Upside

    downward going graph

McKesson share price movements today

Previous Close
$961.88
Open
$968.50
Volume
136.7K
Market Cap
$111.4B
Dividend Yield
0.36%
Day's Low - High
$968.50 - $978.05
52 Week Low - High
$723.68 - $999.00

McKesson Historical Returns

1 Month Return
+ 5.59 %
3 Month Return
+ 19.73 %
1 Year Return
+ 23.02 %
3 Year Return
+ 107.95 %
5 Year Return
+ 373.69 %

McKesson Stock Fundamentals & Key Indicators

Check McKesson market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$111.4B

EPS (TTM)

37.53

Dividend Yield

0.36%

Quarterly Earnings Growth YOY

-0.18%

PE Ratio (TTM)

25.02

Industry PE ratio

19.41

PEG Ratio

0.51

EBITDA

7.3B

Revenue (TTM)

411.0B

Profit Margin

3.64%

Return On Equity TTM

-194.39%

McKesson vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of McKesson with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$111.4B373.69%25.023.64%0.36%
StrongBuy$55.1B392.95%32.683.84%0.86%
Buy$62.0B133.34%23.953.71%0.74%
Buy$9.6B8.19%24.2830.31%0.00%

Stock Returns calculator for McKesson Stock including INR - Dollar returns

The McKesson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

McKesson investment value today

Current value as on today

₹1,33,115

Returns

₹33,115

(+33.11%)

Returns from McKesson Stock

₹24,219 (+24.22%)

Dollar Impact

₹8,896 (+8.9%)

Analyst Recommendation on McKesson Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for McKesson. Average target price of $980.67

McKesson Share Price Target

Get share price movements and forecasts by analysts on McKesson.

What analysts predicted

0.96%UPSIDE

Target Price

$980.67

Current Price

$971.27

Analyzed by

12 Analysts

High

$1080

Target

$980.67

Low

$845

McKesson target price $980.67, a slight upside of 0.96% compared to current price of $971.27. According to 12 analysts rating.

Indian Investors' Interest in McKesson Stock

Search interest for McKesson Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

McKesson Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
76,355
79,283
93,651
95,294
90,823
97,827
103,150
106,158
96,295
105,380
Gross Profit
3,463
2,956
3,146
3,220
2,920
3,279
3,542
3,685
4,044
3,685
Operating Income
1,372
1,061
745
1,287
1,036
1,036
1,468
1,619
2,248
1,319
EBITDA
1,410
1,319
775
1,446
1,711
1,257
1,657
1,843
2,260
1,580
Interest Expense
80
66
78
67
45
49
74
63
-61
77
Depreciation
160
169
163
153
151
157
188
188
196
195
Income Before Tax
1,170
1,084
534
1,226
1,515
1,051
1,395
1,630
2,125
1,308
Income Tax Expense
340
124
247
298
209
220
232
380
270
276
Net Income
791
915
241
879
1,260
784
1,110
1,186
1,682
614
Net Profit Margin
4.54%
3.73%
3.36%
3.38%
3.22%
3.35%
3.43%
3.47%
4.20%
3.50%

McKesson Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
198,533
208,357
214,319
231,051
238,228
263,966
276,711
308,951
359,051
403,430
Gross Profit
10,688
10,392
10,762
11,400
11,582
12,649
11,869
12,202
12,485
14,550
Operating Income
3,357
2,921
3,078
3,012
3,510
2,723
4,453
3,927
4,372
6,454
EBITDA
8,109
1,473
1,823
2,315
-3,930
2,866
5,486
4,667
5,251
7,177
Interest Expense
308
283
264
249
217
178
248
243
256
247
Depreciation
910
951
949
922
887
760
608
635
636
729
Income Before Tax
6,891
239
610
1,144
-5,034
1,928
4,630
3,789
4,359
6,201
Income Tax Expense
1,614
-53
356
18
-695
636
905
629
878
1,102
Net Income
5,183
67
34
900
-4,539
1,114
3,560
3,002
3,295
4,762
Net Profit Margin
5.38%
4.99%
5.02%
4.93%
4.86%
4.79%
4.29%
3.95%
3.48%
3.61%

McKesson Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
830
960
287
928
1,306
784
1,210
1,250
1,682
1,032
Operating Cash Flow
4,147
-1,380
2,100
-2,383
7,748
-918
2,420
1,232
3,421
-220
Investing Cash Flow
-577
-87
-286
-136
-224
-3,564
-24
-269
425
-214
Financing Cash Flow
-968
-809
-1,599
1,298
-2,855
1,176
-961
-2,026
-2,820
1,632
Change in Cash
2,601
-2,283
207
-1,229
4,674
-3,273
1,426
-1,056
1,015
1,188

McKesson Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
5,153
297
33
1,120
-4,340
1,287
3,722
3,160
3,481
4,762
Operating Cash Flow
4,744
4,345
4,036
4,374
4,542
4,434
5,159
4,314
6,085
6,155
Investing Cash Flow
-3,796
-1,522
-1,381
-579
-415
-89
-542
-1,072
-733
-3,432
Financing Cash Flow
-2,069
-3,084
-2,227
-2,734
-1,693
-6,321
-4,368
-3,342
-3,965
-4,631
Change in Cash
-1,265
-111
309
1,042
2,381
-2,461
744
-94
1,371
-1,981

Global Institutional Holdings in McKesson

Check out the Institutions with significant holdings in McKesson.

Funds
Holdings
Vanguard
8.93%
VANGUARD INDEX FUNDS
7.10%
iShares
4.90%
SPDR
4.06%
Fidelity Concord Street Trust
1.83%

McKesson News & Key Events

  • img

    Today's Timeline - 12 October

    Mon, 05:25 PM

    -

    Morgan Stanley downgraded Option Care Health after McKesson's acquisition agreement for $32.05 per share.

    Mon, 06:44 PM

    -

    McKesson partners with EPIC Pharmacies and extends CVS distribution deal through June 2032, projecting significant revenue growth.

    Mon, 07:46 PM

    -

    McKesson extends CVS partnership, with share price trending higher and analysts suggesting a fair value of $980.73.

  • img

    Today's Timeline - 12 October

    Mon, 08:44 PM

    -

    McKesson's $5.8B acquisition of Option Care Health may reshape future cash flows and enhance specialty infusion revenue.

Insights on McKesson

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    McKesson Corporation has experienced a positive trend in revenue over the last two quarters. The revenue increased from $96.29 billion to $105.37 billion, showing an average growth rate of 8.6% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MCK stock has moved up by 5.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Cardinal Health, Inc. has given 157.2% return, outperforming this stock by 49.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Cardinal Health, Inc. has given 55.5% return, outperforming this stock by 32.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    McKesson Corporation's net profit has decreased over the last two quarters. It fell from $1.68 billion to $613.99 million, which represents an average decline of 63.5% per quarter.

About McKesson

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
OrganisationMcKesson
Headquarters6555 State Highway 161, Irving, TX, 75039, US
IndustryMedical - Distribution
CEOBrian S. Tyler

Key Management of McKesson

Name

Title

Mr. Brian S. Tyler Ph.D.

CEO & Chairman

Ms. Michele Lau J.D.

Executive VP & Chief Legal Officer

Ms. LeAnn B. Smith

Executive VP & Chief Human Resources Officer

Mr. Francisco J. Fraga

Executive VP, Chief Information Officer & CTO

Ms. Jeni Dominguez

Head of Investor Relations

Mr. Kenny K. Cheung

Executive VP & CFO

Mr. Napoleon B. Rutledge Jr.

Senior VP, Controller & Chief Accounting Officer

Paula Adkison

Senior Vice President of Corporate Finance, Investor Relations & Strategic Finance

Mr. Kirk Kaminsky

Executive VP & Group President of North American Pharmaceutical Services

Mr. Stanton J. McComb

President of Medical-Surgical

FAQs

What is McKesson share price today?

McKesson share price today is $971.27 as on . McKesson share today touched a day high of $978.05 and a low of $968.50.

What is the 52 week high and 52 week low for McKesson share?

McKesson share touched a 52 week high of $999.00 on and a 52 week low of $723.68 on . McKesson stock price today i.e. is trending at $971.27,which is 2.78% down from its 52 week high and 34.21% up from its 52 week low.

What is McKesson's market capitalisation today?

McKesson market capitalisation is $0.11T as on .

How to invest in McKesson Stock (MCK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for McKesson on INDmoney app. Click on Buy button.

What is the minimum amount required to buy McKesson Stock (MCK) from India?

Indian investors can start investing in McKesson (MCK) shares with as little as ₹95.13999938964844 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.40 in McKesson stock (as per the Rupee-Dollar exchange rate as on ). Based on McKesson share’s latest price of $971.27 as on October 14, 2026 at 10:42 pm IST, you will get 0.0103 shares of McKesson. Learn more about fractional shares .

What are the returns that McKesson has given to Indian investors in the last 5 years?

McKesson stock has given 373.69% share price returns and 27.71% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?